Ordering Publications

To order a hard copy of any of the publications listed below from UCLA ISAP, send the article number (found at the end of the reference, for example "12.1"), the article author/title, and your postal address to:

Kris Langabeer
UCLA Integrated Substance Abuse Programs
1640 S. Sepulveda Blvd., Ste. 200
Los Angeles, CA 90025-7535

Your first 5 articles ordered per year are free, but additional articles are $1 per reprint. Checks should be made out to "UC Regents." Purchase orders will not be accepted for orders under $25.

Publications List (N-P)

(A list of all publications is available as an .rtf file).

Nahom, D., Shoptaw, S., Portnoff, M., & Rawson, R. (1997). Your AIDS IQ. Professional Counselor, 43-45. (01.27)

Nemes, S., Wish, E. D., & Messina, N. (1999). Comparing the impact of standard and abbreviated treatment in a therapeutic community: Findings from the District of Columbia treatment initiative experiment. Journal of Substance Abuse Treatment, 17(4), 339-347. (13.19)

Nemes, S., Wish, E. D., Wraight, B., & Messina, N. (2002). Correlates of treatment follow-up difficulty. Substance Use and Misuse, 37(1), 19-45. (13.24)

Newlin, D. B., Wong, C. J., Stapleton, J. M., & London, E. D. (2000). Intravenous cocaine decreases cardiac vagal tone, vagal index (derived in lorenz space), and heart period complexity (approximate entropy) in cocaine abusers. Neuropsychopharmacology, 23(5), 560-568. (04.49)

Newton, T., Cook, I. A., Kalechstein, A., Duran, S., Monroy, F., Ling, W., & Leuchter, A. F. (2003). Quantitative EEG abnormalities in recently abstinent methamphetamine dependent individuals. Clinical Neurophysiology, 114, 410-415. (28.24)

Newton, T., Kalechstein, A., Beckson, M., Bartzokis, G., Bridge, T. P., & Ling, W. (1999). Effects of selegiline pretreatment on response to experimental cocaine administration. Psychiatry Research, 87(2-3), 101-106. (04.39)

Newton, T., Kalechstein, A., Tervo, K., & Ling, W. (2003). Irritability following abstinence from cocaine predicts euphoric effects of cocaine administration. Addictive Behaviors, 28, 817-821. (04.58)

Newton, T., Khalsa-Denison, M. E., & Gawin, F. H. (1997). The face of craving? Facial muscle EMG and reported craving in abstinent and non-abstinent cocaine users. Psychiatry Research, 73(1-2), 115-118. (04.30)

Newton, T., Ling, W., Kalechstein, A., Uslaner, J., & Tervo, K. (2001). Risperidone pre-treatment reduces the euphoric effects of experimentally administered cocaine. Psychiatry Research, 102(3), 227-233. (04.42)

Noble, E. P., Blum, K., Khalsa, M. E., Ritchie, T., Montgomery, A., Wood, R. C., Fitch, R. J., Ozkaragoz, T., Sheridan, P. J., Anglin, M. D., Paredes, A., Treiman, L. J., & Sparkes, R. S. (1993). Allelic association of the d2 dopamine receptor gene with cocaine dependence. Drug and Alcohol Dependence, 33, 271-285. (04.1)

Nyamathi, A., Leake, B., Longshore, D., & Gelberg, L. (2001). Reliability of homeless women's reports: Concordance between hair assay and self report of cocaine use. Nursing Research, 50(3), 165-171. (21.32)

Nyamathi, A., Stein, J. A., Dixon, E., Longshore, D., & Galaif, E. R. (2003). Predicting positive attitudes about quitting drug and alcohol use among homeless women. Psychology of Addictive Behaviors, 17(1 ), 32-41. (21.33)

O'Leary, A., & The National Inst of Mental Health Multisite HIV Prevention Trial Group. (2001). Social-cognitive theory mediators of behavior change in the national institute of mental health multisite HIV prevention trial. Health Psychology, 20(5), 369-376. (01.80)

Obert, J. L., London, E. D., & Rawson, R. (2002). Incorporating brain research findings into standard treatment: An example using the Matrix model. Journal of Substance Abuse Treatment, 23(2), 107-113. (30.26)

Obert, J. L., McCann, M. J., Marinelli-Casey, P., Weiner, A., Minsky, S., Brethen, P., & Rawson, R. (2000). The Matrix model of outpatient stimulant abuse treatment: History and description. Journal of Psychoactive Drugs, 32(2), 157-164. (18.103)

Parker, L. E., Hser, Y., Hall, E., & Turner, S. (1997). Propensity for exit, voice, patience, and neglect: The role of perceptions of the self and of the situation in selecting response to workplace dissatisfaction. Unpublished manuscript, University of California, Los Angeles, Drug Abuse Research Center. (22.3)

Petry, N. M., & Roll, J. M. (2001). A behavioral approach to understanding and treating pathological gambling. Clinical Neuropsychiatry, 6(3), 117-183. (27.6)

Podus, D., Barron, N., Chang, E., Watkins, K., Guydish, J., & Anglin, M. D. (2003). Medical and mental health services utilization among requalified and former Drug Addiction and Alcoholism recipients of SSI . Contemporary Drug Problems, 30, 365-390. (26.07)

Podus, D., Chang, E., Brecht, M. L., Swartz, J. A., & Anglin, M. D. (2003). Drug use prevalence among former SSI DA&A recipients. Contemporary Drug Problems, 30, 275-290. (26.06)

Podus, D., Watkins, K. E., & Lombardi, E. L. (2000). Drug use and disability payments in Los Angeles County after SSI reform. CPRC Brief, 12(8), 1-4. (26.04)

Pogun, S., Demirgoren, S., Taskiran, D., Kanit, L., Yilmaz, O., Koylu, E. O., Balkan, B., & London, E. D. (2000). Nicotine modulates nitric oxide in rat brain. European Neuropsychopharmacology, 10(6), 463-472. (30.4)

Polinsky, M. L., Hser. Y., Anglin, M. D., & Maglione, M. A. (1995). Drug treatment programs in Los Angeles County. Los Angeles, CA: UCLA Drug Abuse Treatment Center. (24.15)

Polinsky, M. L., Hser, Y., Anglin, M. D., & Maglione, M. A. (1998). Drug-user treatment programs in a large metropolitan area. Substance Use and Misuse, 33(8), 1739-1761. (18.53)

Polinsky, M. L., Hser, Y., & Grella, C. E. (1998). Consideration of special populations in the drug treatment system of a large metropolitan area. Journal of Behavioral Health Services and Research, 25(1), 7-21. (18.74)

Posner, S. F., Collins, L. M., Longshore, D., & Anglin, M. D. (1996). The acquisition and maintenance of safer sexual behaviors among injection drug users. Substance Use and Misuse, 31(14), 1995-2015. (01.45)

Powers, K. I., & Anglin, M. D. (1996). Couples reciprocal influences in narcotics addiction and recovery: A recommendation on treatment strategy. Psychology and Marketing, 13(8), 769-783. (18.46)

Powers, K. I., & Anglin, M. D. (1993). Cumulative versus stabilizing effects of methadone maintenance: A quasi-experimental study using longitudinal self-report data. Evaluation Review, 17(3), 243-270. (10.15)

Powers, K. I., & Anglin, M. D. (1998). A differential assessment of the cumulative versus stabilizing effect of methadone maintenance treatment. Evaluation Review, 22(2), 175-206. (10.30)

Powers, K. I., & Anglin, M. D. (1994). Gender differences in spouse influence on narcotics-related behaviors. Paper presented at the 102nd annual meeting, American Psychological Association, Los Angeles, CA. (09.7)

Powers, K. I., & Anglin, M. D. (1994). Intervention compliers versus resisters among narcotics addicts. Paper presented at the 102nd annual meeting, American Psychological Association, Los Angeles, CA. (18.31)

Powers, K. I., Hanssens, D. M., Hser, Y., & Anglin, M. D. (1993). Long-term time-series forecasting of social interventions for narcotics use and property crime. Mathematical and Computer Modeling: An International Journal, 17(2), 89-107. (06.21)

Powers, K. I., Hanssens, D. M., Hser, Y., & Anglin, M. D. (1991). Measuring the long-term effects of public policy: The case of narcotics use and property crime. Management Science, 37(6), 627-644. (06.17)

Prendergast, M. L. (1998). Addiction lingo could serve to hamper treatment efforts. Alcoholism and Drug Abuse, 10(22), 5. (18.60)

Prendergast, M. L. (1995). Evaluation. In: G. L. Vigdal (Ed.), Planning for alcohol and other drug abuse treatment for adults in the criminal justice system (pp. 91-95). Rockville, MD: U.S. Dept. of Health and Human Services. (13.10)

Prendergast, M. L. (1992). Substance abuse among college students. Unpublished manuscript, University of California, Los Angeles, Drug Abuse Research Center. (05.2)

Prendergast, M. L. (1994). Substance use and abuse among college students: A review of recent literature. Journal of American College Health, 43(3), 99-113. (05.4)

Prendergast, M. L., Anglin, M. D., Maugh, T. H., & Hser, Y. (1994). The effectiveness of treatment for drug abuse. Unpublished manuscript, University of California, Los Angeles, Drug Abuse Research Center. (18.43)

Prendergast, M. L., Anglin, M. D., & Wellisch, J. (1994). Community-based treatment for substance-abusing offenders: Principles and practice of effective service delivery. Paper presented at the International Association of Residential and Community Alternatives Research Conference, Seattle, WA. (18.40)

Prendergast, M. L., Anglin, M. D., & Wellisch, J. (1995). Treatment for drug-abusing offenders under community supervision. Federal Probation, 59(4), 66-75. (18.49)

Prendergast, M. L., & Burdon, W. M. (2000). Diversion programs for drug-abusing offenders: The importance of systems issues. Connection, 3, 8. (03.24)

Prendergast, M. L., & Burdon, W. M. (2002). Integrated systems of care for substance-abusing offenders. In: C. G. Leukefeld, D. Farabee, & F. M. Tims (Eds.), Treatment of drug offenders: Policies and issues (pp. 111-126). New York: Springer Publishing Co. (03.23)

Prendergast, M. L., & Carroll, K. (1993). Substance abuse among young adults: Epidemiology, correlates, and implications for prevention. Unpublished manuscript, University of California, Los Angeles, Drug Abuse Research Center. (05.3)

Prendergast, M. L., Carroll, K., Wellisch, J., & Anglin, M. D. (1992). Framework for a strong rehabilitative element in California's methadone programs: Literature review and recommendations, final report. (Report No. Contract 91-00210). Sacramento, CA: California Department of Alcohol and Drug Programs. (10.21)

Prendergast, M. L., Farabee, D., & Cartier, J. (2001). The impact of in-prison therapeutic community programs on prison management. Journal of Offender Rehabilitation, 32(3), 63-78. (18.87)

Prendergast, M. L., Farabee, D., Cartier, J., & Henkin, S. (2002). Involuntary treatment within a prison setting: Impact on psychosocial change during treatment. Criminal Justice and Behavior, 29(1), 5-26. (03.12)

Prendergast, M. L., Grella, C. E., Perry, S. M., & Anglin, M. D. (1995). Levo-alpha-acetylmethadol (LAAM): clinical, research, and policy issues of a new pharmacotherapy for opioid addiction. Journal of Psychoactive Drugs, 27(3), 239-247. (18.19)

Prendergast, M. L., Hall, E., & Wellisch, J. (2001). An outcome evaluation of the Forever Free Substance Abuse Treatment Program: One-year post-release outcomes. Los Angeles: UCLA Intergrated Substance Abuse Programs. (18.98)

Prendergast, M. L., Hser, Y., Chen, J., & Hsieh, J. (1992). Drug treatment need among offender populations. Paper presented at the 44th annual meeting of the American Society of Criminology, New Orleans, LA. (18.42)

Prendergast, M. L., Hser, Y., & Gil-Rivas, V. (1998). Ethnic differences in longitudinal patterns and consequences of narcotics addiction. Journal of Drug Issues, 28(2), 495-515. (09.10)

Prendergast, M. L., & Maugh, T. H. (1994). Drug courts: Diversion that works. Judges' Journal, 34(3), 10-14, 46-47. (06.25)

Prendergast, M. L., & Podus, D. (1997). Drug abuse treatment effectiveness: Research synthesis through meta-analysis. Unpublished manuscript, University of California, Los Angeles, Drug Abuse Research Center: (18.73)

Prendergast, M. L., & Podus, D. (2000). Drug treatment effectiveness: an examination of conceptual and policy issues. Substance Use and Misuse, 35(12-14), 1629-1657. (18.76)

Prendergast, M. L., & Podus, D. (1999). Methadone debate reflects deep-rooted conflicts in the field. Alcoholism and Drug Abuse Weekly, 11(19), 5. (10.32)

Prendergast, M. L., Podus, D., & Chang, E. (2000). Program factors and treatment outcomes in drug dependence treatment: an examination using meta-analysis. Substance Use and Misuse, 35(12-14), 1931-1965. (18.79)

Prendergast, M. L., Podus, D., Chang, E., & Urada, D. (2002). The effectiveness of drug abuse treatment: Meta-analysis of comparison group studies. Drug and Alcohol Dependence, 67, 53-72. (13.30)

Prendergast, M. L., Podus, D., & McCormack, K. (1998). Bibliography of literature reviews on drug abuse treatment effectiveness. Journal of Substance Abuse Treatment, 15(3), 267-270. (18.72)

Prendergast, M. L., Urada, D., & Podus, D. (2001). Meta-analysis of HIV risk-reduction interventions within drug abuse treatment programs. Journal of Consulting and Clinical Psychology, 69(3), 389-405. (01.50)

Prendergast, M. L., Wellisch, J., & Falkin, G. P. (1995). Assessment of and services for substance-abusing women offenders in community and correctional settings. Prison Journal, 75(2), 240-256. (21.9)

Prendergast, M. L., Wellisch, J., & Falkin, G. P. (1996). Drug treatment for women offenders: Research in brief. Unpublished manuscript, University of California, Los Angeles, Drug Abuse Research Center. (18.39)

Prendergast, M. L., Wellisch, J., & Wong, M. M. (1996). Residential treatment for women parollees following prison-based drug treatment: Treatment experiences, needs and services, outcomes. Prison Journal, 76(3), 253-274. (21.20)

Prendergast, M. L., Wellisch, J., & Wong, M. M. (1996). A study of women on parole who graduated from the Forever Free Substance Abuse Program: Treatment experiences, needs and services, outcomes. Final evaluation report. Sacramento, CA: Office of Substance Abuse Program, California Department of Corrections. (21.16)

Last updated - 02/11/2010

Top of Page

2015 ISAP Publications
2014 ISAP Biennial Report